The interstitium in cardiac repair: role of the immune–stromal cell interplay

Nature Reviews Cardiology

Volumn 15, Issue 10, 2018, Pages 601-616

  Forte, Elvira ^a   Furtado, Milena Bastos ^a   Rosenthal, Nadia ^a,b  

^a JACKSON LABORATORY   (United States)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; MICRORNA; NANOPARTICLE;

ADAPTIVE IMMUNITY; CARDIAC REPAIR; CELL COMMUNICATION; CELL INTERACTION; DENDRITIC CELL; EXOSOME; EXTRACELLULAR MATRIX; HEART FIBROBLAST; HEART FUNCTION; HEART INJURY; HEART INTERSTITIUM; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; MESENCHYME CELL; NONHUMAN; OXIDATIVE STRESS; PERICYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STROMA CELL; TISSUE REGENERATION; TISSUE REPAIR; ANIMAL; CARDIAC MUSCLE CELL; CELL PROLIFERATION; CONVALESCENCE; HEART DISEASE; HEART VENTRICLE; IMMUNOLOGY; IMMUNOTHERAPY; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PROCEDURES; REGENERATION; REGENERATIVE MEDICINE; SIGNAL TRANSDUCTION;

ANIMALS; CELL COMMUNICATION; CELL PROLIFERATION; HEART DISEASES; HEART VENTRICLES; HUMANS; IMMUNOTHERAPY; MYOCYTES, CARDIAC; PHENOTYPE; RECOVERY OF FUNCTION; REGENERATION; REGENERATIVE MEDICINE; SIGNAL TRANSDUCTION; STROMAL CELLS; VENTRICULAR REMODELING;

EID: 85053426682     PISSN: 17595002     EISSN: 17595010     Source Type: Journal    
DOI: 10.1038/s41569-018-0077-x     Document Type: Review

References (259)

1. Rinn, J. L., Bondre, C., Gladstone, H. B., Brown, P. O. & Chang, H. Y. Anatomic demarcation by positional variation in fibroblast gene expression programs. PLOS Genet. 2, e119 (2006)
2. Rinn, J. L. et al. A dermal HOX transcriptional program regulates site-specific epidermal fate. Genes Dev. 22, 303–307 (2008)
3. Nacu, E. et al. Connective tissue cells, but not muscle cells, are involved in establishing the proximo-distal outcome of limb regeneration in the axolotl. Development 140, 513–518 (2013)
4. Benias, P. C. et al. Structure and distribution of an unrecognized interstitium in human tissues. Sci. Rep. 8, 4947 (2018)
5. Forbes, S. J. & Rosenthal, N. Preparing the ground for tissue regeneration: from mechanism to therapy. Nat. Med. 20, 857–869 (2014)
6. Karin, M. & Clevers, H. Reparative inflammation takes charge of tissue regeneration. Nature 529, 307–315 (2016)
7. Hulsmans, M. et al. Macrophages facilitate electrical conduction in the heart. Cell 169, 510–522 (2017)
8. Pellman, J., Zhang, J. & Sheikh, F. Myocyte-fibroblast communication in cardiac fibrosis and arrhythmias: mechanisms and model systems. J. Mol. Cell. Cardiol. 94, 22–31 (2016)
9. Porrello, E. R. et al. Transient regenerative potential of the neonatal mouse heart. Science 331, 1078–1080 (2011)
10. Vivien, C. J., Hudson, J. E. & Porrello, E. R. Evolution, comparative biology and ontogeny of vertebrate heart regeneration. NPJ Regen. Med. 1, 16012 (2016)
11. Almada, A. E. & Wagers, A. J. Molecular circuitry of stem cell fate in skeletal muscle regeneration, ageing and disease. Nat. Rev. Mol. Cell Biol. 17, 267–279 (2016)
12. Lai, S. L. et al. Reciprocal analyses in zebrafish and medaka reveal that harnessing the immune response promotes cardiac regeneration. eLife 6, e25605 (2017)
13. Hui, S. P. et al. Zebrafish regulatory T cells mediate organ-specific regenerative programs. Dev. Cell 43, 659–672 (2017)
14. Godwin, J. W., Debuque, R., Salimova, E. & Rosenthal, N. A. Heart regeneration in the salamander relies on macrophage-mediated control of fibroblast activation and the extracellular landscape. NPJ Regen. Med. 2, 22 (2017)
15. Frodermann, V. & Nahrendorf, M. Neutrophil-macrophage cross-talk in acute myocardial infarction. Eur. Heart J. 38, 198–200 (2017)
16. Bianchi, M. E. DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 81, 1–5 (2007)
17. Bertheloot, D. & Latz, E. HMGB1, IL-1alpha, IL-33 and S100 proteins: dual-function alarmins. Cell. Mol. Immunol. 14, 43–64 (2017)
18. Turner, N. A. Inflammatory and fibrotic responses of cardiac fibroblasts to myocardial damage associated molecular patterns (DAMPs). J. Mol. Cell. Cardiol. 94, 189–200 (2016)
19. Bernardo, M. E. & Fibbe, W. E. Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell 13, 392–402 (2013)
20. Furtado, M. B. & Hasham, M. Properties and immune function of cardiac fibroblasts. Adv. Exp. Med. Biol. 1003, 35–70 (2017)
21. Mescher, A. L. Macrophages and fibroblasts during inflammation and tissue repair in models of organ regeneration. Regeneration 4, 39–53 (2017)
22. Nowarski, R., Jackson, R. & Flavell, R. A. The stromal intervention: regulation of immunity and inflammation at the epithelial-mesenchymal barrier. Cell 168, 362–375 (2017)
23. Zhang, W. et al. Necrotic myocardial cells release damage-associated molecular patterns that provoke fibroblast activation in vitro and trigger myocardial inflammation and fibrosis in vivo. J. Am. Heart Assoc. 4, e001993 (2015)
24. Frangogiannis, N. G. The inflammatory response in myocardial injury, repair, and remodelling. Nat. Rev. Cardiol. 11, 255–265 (2014)
25. Biernacka, A. & Frangogiannis, N. G. Aging and cardiac fibrosis. Aging Dis. 2, 158–173 (2011)
26. Shinde, A. V. & Frangogiannis, N. G. Fibroblasts in myocardial infarction: a role in inflammation and repair. J. Mol. Cell. Cardiol. 70, 74–82 (2014)
27. Sattler, S. & Rosenthal, N. The neonate versus adult mammalian immune system in cardiac repair and regeneration. Biochim. Biophys. Acta 1863, 1813–1821 (2016)
28. Epelman, S. et al. Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity 40, 91–104 (2014)
29. Pinto, A. R. et al. An abundant tissue macrophage population in the adult murine heart with a distinct alternatively-activated macrophage profile. PLOS ONE 7, e36814 (2012)
30. Skelly, D. A. et al. Single-cell transcriptional profiling reveals cellular diversity and intercommunication in the mouse heart. Cell Rep. 22, 600–610 (2018)
31. Ma, Y., Yabluchanskiy, A. & Lindsey, M. L. Neutrophil roles in left ventricular remodeling following myocardial infarction. Fibrogen. Tissue Repair 6, 11 (2013)
32. Horckmans, M. et al. Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype. Eur. Heart J. 38, 187–197 (2017)
33. Summers, C. et al. Neutrophil kinetics in health and disease. Trends Immunol. 31, 318–324 (2010)
34. Ravichandran, K. S. Beginnings of a good apoptotic meal: the find-me and eat-me signaling pathways. Immunity 35, 445–455 (2011)
35. Ortega-Gomez, A., Perretti, M. & Soehnlein, O. Resolution of inflammation: an integrated view. EMBO Mol. Med. 5, 661–674 (2013)
36. Nahrendorf, M. et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 204, 3037–3047 (2007)
37. Leuschner, F. et al. Angiotensin-converting enzyme inhibition prevents the release of monocytes from their splenic reservoir in mice with myocardial infarction. Circ. Res. 107, 1364–1373 (2010)
38. Seeley, E. J., Barry, S. S., Narala, S., Matthay, M. A. & Wolters, P. J. Noradrenergic neurons regulate monocyte trafficking and mortality during gram-negative peritonitis in mice. J. Immunol. 190, 4717–4724 (2013)
39. Martelli, D., McKinley, M. J. & McAllen, R. M. The cholinergic anti-inflammatory pathway: a critical review. Auton. Neurosci. 182, 65–69 (2014)
40. Frangogiannis, N. G., Smith, C. W. & Entman, M. L. The inflammatory response in myocardial infarction. Cardiovasc. Res. 53, 31–47 (2002)
41. Gonzalez-Rosa, J. M. et al. Myocardial polyploidization creates a barrier to heart regeneration in zebrafish. Dev. Cell 44, 433–446 (2018)
42. Mohamed, T. M. A. et al. Regulation of cell cycle to stimulate adult cardiomyocyte proliferation and cardiac regeneration. Cell 173, 104–116 (2018)
43. Gourko H. In The Evolutionary Biology Papers of Elie Metchnikoff. (eds. Gourko H., Williamson D. I. & Tauber A.I.) 207–216 (Springer, Dordrecht, 2000)
44. Guilliams, M. et al. Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nat. Rev. Immunol. 14, 571–578 (2014)
45. Tauber, A. I. Metchnikoff and the phagocytosis theory. Nat. Rev. Mol. Cell Biol. 4, 897–901 (2003)
46. Ramos, G. C. Inflammation as an animal development phenomenon. Clin. Dev. Immunol. 2012, 983203 (2012)
47. Leid, J. et al. Primitive embryonic macrophages are required for coronary development and maturation. Circ. Res. 118, 1498–1511 (2016)
48. Aurora, A. B. et al. Macrophages are required for neonatal heart regeneration. J. Clin. Invest. 124, 1382–1392 (2014)
49. Honold, L. & Nahrendorf, M. Resident and monocyte-derived macrophages in cardiovascular disease. Circ. Res. 122, 113–127 (2018)
50. Lavine, K. J. et al. Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and remodeling in the neonatal and adult heart. Proc. Natl Acad. Sci. USA 111, 16029–16034 (2014)
51. Leuschner, F. et al. Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J. Exp. Med. 209, 123–137 (2012)
52. Barth, M. W., Hendrzak, J. A., Melnicoff, M. J. & Morahan, P. S. Review of the macrophage disappearance reaction. J. Leukoc. Biol. 57, 361–367 (1995)
53. Davies, L. C., Jenkins, S. J., Allen, J. E. & Taylor, P. R. Tissue-resident macrophages. Nat. Immunol. 14, 986–995 (2013)
54. Martinez, F. O. & Gordon, S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 6, 13 (2014)
55. Nahrendorf, M. & Swirski, F. K. Abandoning M1/M2 for a network model of macrophage function. Circ. Res. 119, 414–417 (2016)
56. Bruttger, J. et al. Genetic cell ablation reveals clusters of local self-renewing microglia in the mammalian central nervous system. Immunity 43, 92–106 (2015)
57. Price, J. G. et al. CDKN1A regulates Langerhans cell survival and promotes Treg cell generation upon exposure to ionizing irradiation. Nat. Immunol. 16, 1060–1068 (2015)
58. Ginhoux, F. et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330, 841–845 (2010)
59. Hashimoto, D. et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity 38, 792–804 (2013)
60. Hoeffel, G. et al. Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac-derived macrophages. J. Exp. Med. 209, 1167–1181 (2012)
61. Schulz, C. et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 336, 86–90 (2012)
62. Yona, S. et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 38, 79–91 (2013)
63. Gautier, E. L. et al. Systemic analysis of PPARgamma in mouse macrophage populations reveals marked diversity in expression with critical roles in resolution of inflammation and airway immunity. J. Immunol. 189, 2614–2624 (2012)
64. Gosselin, D. et al. Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell 159, 1327–1340 (2014)
65. Lavin, B. et al. Nitric oxide prevents aortic neointimal hyperplasia by controlling macrophage polarization. Arterioscler. Thromb. Vasc. Biol. 34, 1739–1746 (2014)
66. Lavin, Y. et al. Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell 159, 1312–1326 (2014)
67. Molawi, K. et al. Progressive replacement of embryo-derived cardiac macrophages with age. J. Exp. Med. 211, 2151–2158 (2014)
68. Pinto, A. R. et al. Age-related changes in tissue macrophages precede cardiac functional impairment. Aging 6, 399–413 (2014)
69. Steinman, R. M. & Cohn, Z. A. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med. 137, 1142–1162 (1973)
70. Zhang, Y. & Zhang, C. Role of dendritic cells in cardiovascular diseases. World J. Cardiol. 2, 357–364 (2010)
71. Merad, M. & Manz, M. G. Dendritic cell homeostasis. Blood 113, 3418–3427 (2009)
72. Zhang, J., Yu, Z. X., Fujita, S., Yamaguchi, M. L. & Ferrans, V. J. Interstitial dendritic cells of the rat heart. Quantitative and ultrastructural changes in experimental myocardial infarction. Circulation 87, 909–920 (1993)
73. Gallego-Colon, E. et al. Cardiac-restricted IGF-1Ea overexpression reduces the early accumulation of inflammatory myeloid cells and mediates expression of extracellular matrix remodelling genes after myocardial infarction. Mediators Inflamm. 2015, 484357 (2015)
74. Anzai, A. et al. Regulatory role of dendritic cells in postinfarction healing and left ventricular remodeling. Circulation 125, 1234–1245 (2012)
75. Hofmann, U. et al. Activation of CD4+ T lymphocytes improves wound healing and survival after experimental myocardial infarction in mice. Circulation 125, 1652–1663 (2012)
76. Nagai, T. et al. Decreased myocardial dendritic cells is associated with impaired reparative fibrosis and development of cardiac rupture after myocardial infarction in humans. J. Am. Heart Assoc. 3, e000839 (2014)
77. Sattler, S., Fairchild, P., Watt, F. M., Rosenthal, N. & Harding, S. E. The adaptive immune response to cardiac injury-the true roadblock to effective regenerative therapies? NPJ Regen. Med. 2, 19 (2017)
78. Godwin, J. W., Pinto, A. R. & Rosenthal, N. A. Chasing the recipe for a pro-regenerative immune system. Semin. Cell Dev. Biol. 61, 71–79 (2017)
79. Hofmann, U. & Frantz, S. Role of lymphocytes in myocardial injury, healing, and remodeling after myocardial infarction. Circ. Res. 116, 354–367 (2015)
80. Zouggari, Y. et al. B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nat. Med. 19, 1273–1280 (2013)
81. Nian, M., Lee, P., Khaper, N. & Liu, P. Inflammatory cytokines and postmyocardial infarction remodeling. Circ. Res. 94, 1543–1553 (2004)
82. Porter, K. E. & Turner, N. A. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol. Ther. 123, 255–278 (2009)
83. Tang, T. T. et al. Regulatory T cells ameliorate cardiac remodeling after myocardial infarction. Basic Res. Cardiol. 107, 232 (2012)
84. Kim, J. M., Rasmussen, J. P. & Rudensky, A. Y. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8, 191–197 (2007)
85. Furtado, M. B., Nim, H. T., Boyd, S. E. & Rosenthal, N. A. View from the heart: cardiac fibroblasts in development, scarring and regeneration. Development 143, 387–397 (2016)
86. Pinto, A. R. et al. Revisiting cardiac cellular composition. Circ. Res. 118, 400–409 (2016)
87. Goldsmith, E. C. et al. Organization of fibroblasts in the heart. Dev. Dyn. 230, 787–794 (2004)
88. Bowers, S. L., Borg, T. K. & Baudino, T. A. The dynamics of fibroblast-myocyte-capillary interactions in the heart. Ann. NY Acad. Sci. 1188, 143–152 (2010)
89. Camelliti, P., Borg, T. K. & Kohl, P. Structural and functional characterisation of cardiac fibroblasts. Cardiovasc. Res. 65, 40–51 (2005)
90. Kohl, P., Kamkin, A. G., Kiseleva, I. S. & Noble, D. Mechanosensitive fibroblasts in the sino-atrial node region of rat heart: interaction with cardiomyocytes and possible role. Exp. Physiol. 79, 943–956 (1994)
91. Ongstad, E. & Kohl, P. Fibroblast-myocyte coupling in the heart: potential relevance for therapeutic interventions. J. Mol. Cell. Cardiol. 91, 238–246 (2016)
92. Ali, S. R. et al. Developmental heterogeneity of cardiac fibroblasts does not predict pathological proliferation and activation. Circ. Res. 115, 625–635 (2014)
93. Moore-Morris, T. et al. Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis. J. Clin. Invest. 124, 2921–2934 (2014)
94. Moore-Morris, T., Tallquist, M. D. & Evans, S. M. Sorting out where fibroblasts come from. Circ. Res. 115, 602–604 (2014)
95. Tallquist, M. D. & Molkentin, J. D. Redefining the identity of cardiac fibroblasts. Nat. Rev. Cardiol. 14, 484–491 (2017)
96. Bani, D. & Nistri, S. New insights into the morphogenic role of stromal cells and their relevance for regenerative medicine. lessons from the heart. J. Cell. Mol. Med. 18, 363–370 (2014)
97. Ieda, M. et al. Cardiac fibroblasts regulate myocardial proliferation through beta1 integrin signaling. Dev. Cell 16, 233–244 (2009)
98. Lajiness, J. D. & Conway, S. J. The dynamic role of cardiac fibroblasts in development and disease. J. Cardiovasc. Transl Res. 5, 739–748 (2012)
99. Quaife-Ryan, G. A. et al. Multicellular transcriptional analysis of mammalian heart regeneration. Circulation 136, 1123–1139 (2017)
100. Kanisicak, O. et al. Genetic lineage tracing defines myofibroblast origin and function in the injured heart. Nat. Commun. 7, 12260 (2016)
101. Moore-Morris, T. et al. Infarct fibroblasts do not derive from bone marrow lineages. Circ. Res. 122, 583–590 (2018)
102. Acharya, A. et al. The bHLH transcription factor Tcf21 is required for lineage-specific EMT of cardiac fibroblast progenitors. Development 139, 2139–2149 (2012)
103. Bryant, D. M. et al. A systematic analysis of neonatal mouse heart regeneration after apical resection. J. Mol. Cell. Cardiol. 79, 315–318 (2015)
104. Notari, M. et al. The local microenvironment limits the regenerative potential of the mouse neonatal heart. Sci. Adv. 4, eaao5553 (2018)
105. Furtado, M. B., Costa, M. W. & Rosenthal, N. A. The cardiac fibroblast: origin, identity and role in homeostasis and disease. Differentiation 92, 93–101 (2016)
106. Bassat, E. et al. The extracellular matrix protein agrin promotes heart regeneration in mice. Nature 547, 179–184 (2017)
107. Eroglu, E. & Chien, K. R. Heart regeneration 4.0: matrix medicine. Dev. Cell 42, 7–8 (2017)
108. Furtado, M. B. et al. Cardiogenic genes expressed in cardiac fibroblasts contribute to heart development and repair. Circ. Res. 114, 1422–1434 (2014)
109. Ivey, M. J. & Tallquist, M. D. Defining the cardiac fibroblast. Circ. J. 80, 2269–2276 (2016)
110. Doppler, S. A. et al. Cardiac fibroblasts: more than mechanical support. J. Thorac. Dis. 9, S36–S51 (2017)
111. Ivey, M. J. et al. Resident fibroblast expansion during cardiac growth and remodeling. J. Mol. Cell. Cardiol. 114, 161–174 (2018)
112. El Agha, E. et al. Two-way conversion between lipogenic and myogenic fibroblastic phenotypes marks the progression and resolution of lung fibrosis. Cell Stem Cell 20, 261–273 (2017)
113. Paylor, B., Fernandes, J., McManus, B. & Rossi, F. Tissue-resident Sca1+ PDGFRalpha+ mesenchymal progenitors are the cellular source of fibrofatty infiltration in arrhythmogenic cardiomyopathy. F1000Res. 2, 141 (2013)
114. Lombardi, R. et al. Cardiac fibro-adipocyte progenitors express desmosome proteins and preferentially differentiate to adipocytes upon deletion of the desmoplakin gene. Circ. Res. 119, 41–54 (2016)
115. Pillai, I. C. L. et al. Cardiac fibroblasts adopt osteogenic fates and can be targeted to attenuate pathological heart calcification. Cell Stem Cell 20, 218–232 (2017)
116. Fu, X. et al. Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart. J. Clin. Invest. 128, 2127–2143 (2018)
117. Chang, Y., Li, H. & Guo, Z. Mesenchymal stem cell-like properties in fibroblasts. Cell. Physiol. Biochem. 34, 703–714 (2014)
118. Denu, R. A. et al. Fibroblasts and mesenchymal stromal/stem cells are phenotypically indistinguishable. Acta Haematol. 136, 85–97 (2016)
119. Haniffa, M. A., Collin, M. P., Buckley, C. D. & Dazzi, F. Mesenchymal stem cells: the fibroblasts’ new clothes? Haematologica 94, 258–263 (2009)
120. Hematti, P. Mesenchymal stromal cells and fibroblasts: a case of mistaken identity? Cytotherapy 14, 516–521 (2012)
121. Covas, D. T. et al. Mesenchymal stem cells can be obtained from the human saphena vein. Exp. Cell Res. 309, 340–344 (2005)
122. Covas, D. T. et al. Mesenchymal stem cells, fibroblasts and pericytes: different functional states of the same cell? Blood 106, 4310 (2005)
123. Dominici, M. et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315–317 (2006)
124. Menard, C. & Tarte, K. Immunoregulatory properties of clinical grade mesenchymal stromal cells: evidence, uncertainties, and clinical application. Stem Cell Res. Ther. 4, 64 (2013)
125. Cai, C. L. & Molkentin, J. D. The elusive progenitor cell in cardiac regeneration: slip slidin’ away. Circ. Res. 120, 400–406 (2017)
126. Armulik, A., Genove, G. & Betsholtz, C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev. Cell 21, 193–215 (2011)
127. Chen, C. et al. Perivascular multi-lineage progenitor cells in human organs: regenerative units, cytokine sources or both? Cytokine Growth Factor Rev. 20, 429–434 (2009)
128. Katare, R. et al. Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132. Circul. Res. 109, 894–906 (2011)
129. Corselli, M., Chen, C. W., Crisan, M., Lazzari, L. & Peault, B. Perivascular ancestors of adult multipotent stem cells. Arterioscler. Thromb. Vasc. Biol. 30, 1104–1109 (2010)
130. Ferland-McCollough, D., Slater, S., Richard, J., Reni, C. & Mangialardi, G. Pericytes, an overlooked player in vascular pathobiology. Pharmacol. Ther. 171, 30–42 (2017)
131. Kramann, R. et al. Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis. Cell Stem Cell 16, 51–66 (2015)
132. Halade, G. V. Targeting resolution of inflammation following myocardial infarction. J. Cardiol. Clin. Res. 1, 1008 (2013)
133. Prabhu, S. D. & Frangogiannis, N. G. The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ. Res. 119, 91–112 (2016)
134. Zeigler, A. C., Richardson, W. J., Holmes, J. W. & Saucerman, J. J. Computational modeling of cardiac fibroblasts and fibrosis. J. Mol. Cell. Cardiol. 93, 73–83 (2016)
135. Baudino, T. A., Carver, W., Giles, W. & Borg, T. K. Cardiac fibroblasts: friend or foe? Am. J. Physiol. Heart Circ. Physiol. 291, H1015–H1026 (2006)
136. Martin, M. L. & Blaxall, B. C. Cardiac intercellular communication: are myocytes and fibroblasts fair-weather friends? J. Cardiovasc. Transl Res. 5, 768–782 (2012)
137. Emanueli, C., Shearn, A. I., Angelini, G. D. & Sahoo, S. Exosomes and exosomal miRNAs in cardiovascular protection and repair. Vascul. Pharmacol. 71, 24–30 (2015)
138. Yuan, M. J., Maghsoudi, T. & Wang, T. Exosomes mediate the intercellular communication after myocardial infarction. Int. J. Med. Sci. 13, 113–116 (2016)
139. Zhang, Y., Hu, Y. W., Zheng, L. & Wang, Q. Characteristics and roles of exosomes in cardiovascular disease. DNA Cell Biol. 36, 202–211 (2017)
140. Turner, N. A. et al. Mechanism of TNFalpha-induced IL-1alpha, IL-1beta and IL-6 expression in human cardiac fibroblasts: effects of statins and thiazolidinediones. Cardiovasc. Res. 76, 81–90 (2007)
141. Turner, N. A. et al. Interleukin-1alpha stimulates proinflammatory cytokine expression in human cardiac myofibroblasts. Am. J. Physiol. Heart Circ. Physiol. 297, H1117–H1127 (2009)
142. Ma, Y., Iyer, R. P., Jung, M., Czubryt, M. P. & Lindsey, M. L. Cardiac fibroblast activation post-myocardial infarction: current knowledge gaps. Trends Pharmacol. Sci. 38, 448–458 (2017)
143. Kawaguchi, M. et al. Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury. Circulation 123, 594–604 (2011)
144. Lindner, D. et al. Cardiac fibroblasts support cardiac inflammation in heart failure. Basic Res. Cardiol. 109, 428 (2014)
145. Nakaya, M. et al. Cardiac myofibroblast engulfment of dead cells facilitates recovery after myocardial infarction. J. Clin. Invest. 127, 383–401 (2017)
146. Bhide, V. M. et al. Collagen phagocytosis by fibroblasts is regulated by decorin. J. Biol. Chem. 280, 23103–23113 (2005)
147. Hall, S. E., Savill, J. S., Henson, P. M. & Haslett, C. Apoptotic neutrophils are phagocytosed by fibroblasts with participation of the fibroblast vitronectin receptor and involvement of a mannose/fucose-specific lectin. J. Immunol. 153, 3218–3227 (1994)
148. Arlein, W. J., Shearer, J. D. & Caldwell, M. D. Continuity between wound macrophage and fibroblast phenotype: analysis of wound fibroblast phagocytosis. Am. J. Physiol. 275, R1041–R1048 (1998)
149. Aurora, A. B. & Olson, E. N. Immune modulation of stem cells and regeneration. Cell Stem Cell 15, 14–25 (2014)
150. Heredia, J. E. et al. Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration. Cell 153, 376–388 (2013)
151. Swonger, J. M., Liu, J. S., Ivey, M. J. & Tallquist, M. D. Genetic tools for identifying and manipulating fibroblasts in the mouse. Differentiation 92, 66–83 (2016)
152. Liehn, E. A., Postea, O., Curaj, A. & Marx, N. Repair after myocardial infarction, between fantasy and reality: the role of chemokines. J. Am. Coll. Cardiol. 58, 2357–2362 (2011)
153. Saxena, A. et al. IL-1 induces proinflammatory leukocyte infiltration and regulates fibroblast phenotype in the infarcted myocardium. J. Immunol. 191, 4838–4848 (2013)
154. Wang, Y., Chen, X., Cao, W. & Shi, Y. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications. Nat. Immunol. 15, 1009–1016 (2014)
155. Kaplan, J. M., Youd, M. E. & Lodie, T. A. Immunomodulatory activity of mesenchymal stem cells. Curr. Stem Cell Res. Ther. 6, 297–316 (2011)
156. Qi, K., Li, N., Zhang, Z. & Melino, G. Tissue regeneration: the crosstalk between mesenchymal stem cells and immune response. Cell. Immunol. 326, 86–93 (2017)
157. Dobaczewski, M. et al. Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction. Circ. Res. 107, 418–428 (2010)
158. Zhou, B. et al. Adult mouse epicardium modulates myocardial injury by secreting paracrine factors. J. Clin. Invest. 121, 1894–1904 (2011)
159. Rog-Zielinska, E. A., Norris, R. A., Kohl, P. & Markwald, R. The living scar — cardiac fibroblasts and the injured heart. Trends Mol. Med. 22, 99–114 (2016)
160. Minicucci, M. F., Azevedo, P. S., Polegato, B. F., Paiva, S. A. & Zornoff, L. A. Heart failure after myocardial infarction: clinical implications and treatment. Clin. Cardiol. 34, 410–414 (2011)
161. Lakhin, A. V., Tarantul, V. Z. & Gening, L. V. Aptamers: problems, solutions and prospects. Acta Naturae 5, 34–43 (2013)
162. Dou, X. Q. et al. Aptamer-drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity. Int. J. Nanomed. 13, 763–776 (2018)
163. Ngo, D. et al. Aptamer-based proteomic profiling reveals novel candidate biomarkers and pathways in cardiovascular disease. Circulation 134, 270–285 (2016)
164. 2+ transients and contractile function in cardiomyocytes. J. Mol. Cell. Cardiol. 76, 177–185 (2014)
165. Li, J., Yousefi, K., Ding, W., Singh, J. & Shehadeh, L. A. Osteopontin RNA aptamer can prevent and reverse pressure overload-induced heart failure. Cardiovasc. Res. 113, 633–643 (2017)
166. Wallukat, G. et al. Aptamer BC007 for neutralization of pathogenic autoantibodies directed against G-protein coupled receptors: a vision of future treatment of patients with cardiomyopathies and positivity for those autoantibodies. Atherosclerosis 244, 44–47 (2016)
167. Haberland, A. et al. Neutralization of pathogenic beta1-receptor autoantibodies by aptamers in vivo: the first successful proof of principle in spontaneously hypertensive rats. Mol. Cell. Biochem. 393, 177–180 (2014)
168. Port, J. D. & Bristow, M. R. Aptamer therapy for heart failure? Circ. Res. 109, 982–983 (2011)
169. Nimjee, S. M., Povsic, T. J., Sullenger, B. A. & Becker, R. C. Translation and clinical development of antithrombotic aptamers. Nucleic Acid. Ther. 26, 147–155 (2016)
170. Jilma, B. et al. A randomised pilot trial of the anti-von Willebrand factor aptamer ARC1779 in patients with type 2b von Willebrand disease. Thromb. Haemost. 104, 563–570 (2010)
171. Lincoff, A. M. et al. Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial. Lancet 387, 349–356 (2016)
172. Povsic, T. J. et al. A randomized, partially blinded, multicenter, active-controlled, dose-ranging study assessing the safety, efficacy, and pharmacodynamics of the REG1 anticoagulation system in patients with acute coronary syndromes: design and rationale of the RADAR Phase IIb trial. Am. Heart J. 161, 261–268 (2011)
173. Povsic, T. J. et al. A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial. Eur. Heart J. 34, 2481–2489 (2013)
174. Povsic, T. J. et al. Pegnivacogin results in near complete FIX inhibition in acute coronary syndrome patients: RADAR pharmacokinetic and pharmacodynamic substudy. Eur. Heart J. 32, 2412–2419 (2011)
175. Staudacher, D. L. et al. Direct factor IXa inhibition with the RNA-aptamer pegnivacogin reduces platelet reactivity in vitro and residual platelet aggregation in patients with acute coronary syndromes. Eur. Heart J. Acute Cardiovasc. Care 10.1177/2048872617703065 (2017)
176. Hinderer, S., Brauchle, E. & Schenke-Layland, K. Generation and assessment of functional biomaterial scaffolds for applications in cardiovascular tissue engineering and regenerative medicine. Adv. Healthc. Mater. 4, 2326–2341 (2015)
177. Reis, L. A., Chiu, L. L., Feric, N., Fu, L. & Radisic, M. Biomaterials in myocardial tissue engineering. J. Tissue Eng. Regen Med. 10, 11–28 (2016)
178. Amir, G. et al. Evaluation of a peritoneal-generated cardiac patch in a rat model of heterotopic heart transplantation. Cell Transplant. 18, 275–282 (2009)
179. Dvir, T. et al. Prevascularization of cardiac patch on the omentum improves its therapeutic outcome. Proc. Natl Acad. Sci. USA 106, 14990–14995 (2009)
180. Christman, K. L. et al. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J. Am. Coll. Cardiol. 44, 654–660 (2004)
181. Yu, J. et al. Restoration of left ventricular geometry and improvement of left ventricular function in a rodent model of chronic ischemic cardiomyopathy. J. Thorac. Cardiovasc. Surg. 137, 180–187 (2009)
182. Chiu, L. L. & Radisic, M. Scaffolds with covalently immobilized VEGF and Angiopoietin-1 for vascularization of engineered tissues. Biomaterials 31, 226–241 (2010)
183. Zimmermann, W. H. et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat. Med. 12, 452–458 (2006)
184. Zimmermann, W. H. et al. Tissue engineering of a differentiated cardiac muscle construct. Circ. Res. 90, 223–230 (2002)
185. Matsubayashi, K. et al. Improved left ventricular aneurysm repair with bioengineered vascular smooth muscle grafts. Circulation 108 (Suppl. 1), 219–225 (2003)
186. Madden, L. R. et al. Proangiogenic scaffolds as functional templates for cardiac tissue engineering. Proc. Natl Acad. Sci. USA 107, 15211–15216 (2010)
187. Yeong, W. Y. et al. Porous polycaprolactone scaffold for cardiac tissue engineering fabricated by selective laser sintering. Acta Biomater. 6, 2028–2034 (2010)
188. Lesman, A. et al. Transplantation of a tissue-engineered human vascularized cardiac muscle. Tissue Eng. Part A 16, 115–125 (2010)
189. Rai, R. et al. Biomimetic poly(glycerol sebacate) (PGS) membranes for cardiac patch application. Mater. Sci. Eng. C Mater. Biol. Appl. 33, 3677–3687 (2013)
190. Ott, H. C. et al. Perfusion-decellularized matrix: using nature’s platform to engineer a bioartificial heart. Nat. Med. 14, 213–221 (2008)
191. Guyette, J. P. et al. Bioengineering human myocardium on native extracellular matrix. Circ. Res. 118, 56–72 (2016)
192. Sanchez, P. L. et al. Acellular human heart matrix: a critical step toward whole heart grafts. Biomaterials 61, 279–289 (2015)
193. Kitahara, H. et al. Heterotopic transplantation of a decellularized and recellularized whole porcine heart. Interact. Cardiovasc. Thorac Surg. 22, 571–579 (2016)
194. Kinch, M. S. An overview of FDA-approved biologics medicines. Drug Discov. Today 20, 393–398 (2015)
195. Alvarez, P. & Briasoulis, A. Immune modulation in heart failure: the promise of novel biologics. Curr. Treat. Options Cardiovasc. Med. 20, 26 (2018)
196. Roubille, C., Martel-Pelletier, J., Haraoui, B., Tardif, J. C. & Pelletier, J. P. Biologics and the cardiovascular system: a double-edged sword. Antiinflamm. Antiallergy Agents Med. Chem. 12, 68–82 (2013)
197. Becker, N. P., Muller, J., Gottel, P., Wallukat, G. & Schimke, I. Cardiomyopathy — an approach to the autoimmune background. Autoimmun. Rev. 16, 269–286 (2017)
198. Kapur, N. K. et al. Reduced endoglin activity limits cardiac fibrosis and improves survival in heart failure. Circulation 125, 2728–2738 (2012)
199. Zhou, Y., Li, Y. & Mu, T. HMGB1 neutralizing antibody attenuates cardiac injury and apoptosis induced by hemorrhagic shock/resuscitation in rats. Biol. Pharm. Bull. 38, 1150–1160 (2015)
200. Small, E. M. & Olson, E. N. Pervasive roles of microRNAs in cardiovascular biology. Nature 469, 336–342 (2011)
201. Ali, S. S. et al. Pathological microRNAs in acute cardiovascular diseases and microRNA therapeutics. J. Acute Dis. 5, 9–15 (2016)
202. Chistiakov, D. A., Orekhov, A. N. & Bobryshev, Y. V. Cardiac-specific miRNA in cardiogenesis, heart function, and cardiac pathology (with focus on myocardial infarction). J. Mol. Cell. Cardiol. 94, 107–121 (2016)
203. Yu, X., Hong, F. & Zhang, Y. Q. Bio-effect of nanoparticles in the cardiovascular system. J. Biomed. Mater. Res. A 104, 2881–2897 (2016)
204. Suarez, S., Almutairi, A. & Christman, K. L. Micro- and nanoparticles for treating cardiovascular disease. Biomater. Sci. 3, 564–580 (2015)
205. Chang, M. Y. et al. Functionalized nanoparticles provide early cardioprotection after acute myocardial infarction. J. Control. Release 170, 287–294 (2013)
206. Dvir, T. et al. Nanoparticles targeting the infarcted heart. Nano Lett. 11, 4411–4414 (2011)
207. Feld, S. et al. Reduction of canine infarct size by bolus intravenous administration of liposomal prostaglandin E1: comparison with control, placebo liposomes, and continuous intravenous infusion of prostaglandin E1. Am. Heart J. 132, 747–757 (1996)
208. Scott, R. C. et al. Targeting VEGF-encapsulated immunoliposomes to MI heart improves vascularity and cardiac function. FASEB J. 23, 3361–3367 (2009)
209. Verma, D. D., Hartner, W. C., Levchenko, T. S., Bernstein, E. A. & Torchilin, V. P. ATP-loaded liposomes effectively protect the myocardium in rabbits with an acute experimental myocardial infarction. Pharm. Res. 22, 2115–2120 (2005)
210. Verma, D. D., Levchenko, T. S., Bernstein, E. A. & Torchilin, V. P. ATP-loaded liposomes effectively protect mechanical functions of the myocardium from global ischemia in an isolated rat heart model. J. Control. Release 108, 460–471 (2005)
211. Batrakova, E. V. & Kim, M. S. Using exosomes, naturally-equipped nanocarriers, for drug delivery. J. Control. Release 219, 396–405 (2015)
212. Sahoo, S. & Losordo, D. W. Exosomes and cardiac repair after myocardial infarction. Circ. Res. 114, 333–344 (2014)
213. Bang, C. et al. Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. J. Clin. Invest. 124, 2136–2146 (2014)
214. Gladka, M. M. et al. Single-cell sequencing of the healthy and diseased heart reveals ckap4 as a new modulator of fibroblasts activation. Circulation 138, 166–180 (2018)
215. Waardenberg, A. J., Ramialison, M., Bouveret, R. & Harvey, R. P. Genetic networks governing heart development. Cold Spring Harb. Perspect. Med. 4, a013839 (2014)
216. Zeng, B., Ren, X. F., Cao, F., Zhou, X. Y. & Zhang, J. Developmental patterns and characteristics of epicardial cell markers Tbx18 and Wt1 in murine embryonic heart. J. Biomed. Sci. 18, 67 (2011)
217. Epstein, J. A. & Franklin, H. Epstein lecture. Cardiac development and implications for heart disease. N. Engl. J. Med. 363, 1638–1647 (2010)
218. Beltrami, A. P. et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114, 763–776 (2003)
219. Oh, H. et al. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc. Natl Acad. Sci. USA 100, 12313–12318 (2003)
220. Noseda, M. et al. PDGFRalpha demarcates the cardiogenic clonogenic Sca1+ stem/progenitor cell in adult murine myocardium. Nat. Commun. 6, 6930 (2015)
221. Asakura, A. & Rudnicki, M. A. Side population cells from diverse adult tissues are capable of in vitro hematopoietic differentiation. Exp. Hematol. 30, 1339–1345 (2002)
222. Chong, J. J. et al. Adult cardiac-resident MSC-like stem cells with a proepicardial origin. Cell Stem Cell 9, 527–540 (2011)
223. Laugwitz, K. L. et al. Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433, 647–653 (2005)
224. Smart, N. et al. De novo cardiomyocytes from within the activated adult heart after injury. Nature 474, 640–644 (2011)
225. Norris, R. A. et al. Expression of the familial cardiac valvular dystrophy gene, filamin-A, during heart morphogenesis. Dev. Dyn. 239, 2118–2127 (2010)
226. Takeda, N. et al. Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload. J. Clin. Invest. 120, 254–265 (2010)
227. Sato, T. N. et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376, 70–74 (1995)
228. Newman, P. J. et al. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 247, 1219–1222 (1990)
229. Xiao, Q. et al. Sca-1+ progenitors derived from embryonic stem cells differentiate into endothelial cells capable of vascular repair after arterial injury. Arterioscler. Thromb. Vasc. Biol. 26, 2244–2251 (2006)
230. Zachary, I. & Gliki, G. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family. Cardiovasc. Res. 49, 568–581 (2001)
231. Wilhelmi, M. H., Leyh, R. G., Wilhelmi, M. & Haverich, A. Upregulation of endothelial adhesion molecules in hearts with congestive and ischemic cardiomyopathy: immunohistochemical evaluation of inflammatory endothelial cell activation. Eur. J. Cardiothorac. Surg. 27, 122–127 (2005)
232. Duim, S. N., Kurakula, K., Goumans, M. J. & Kruithof, B. P. Cardiac endothelial cells express Wilms’ tumor-1: Wt1 expression in the developing, adult and infarcted heart. J. Mol. Cell. Cardiol. 81, 127–135 (2015)
233. Breviario, F. et al. Functional properties of human vascular endothelial cadherin (7B4/cadherin-5), an endothelium-specific cadherin. Arterioscler. Thromb. Vasc. Biol. 15, 1229–1239 (1995)
234. Katz, T. C. et al. Distinct compartments of the proepicardial organ give rise to coronary vascular endothelial cells. Dev. Cell 22, 639–650 (2012)
235. Jackson, D. G. The lymphatics revisited: new perspectives from the hyaluronan receptor LYVE-1. Trends Cardiovasc. Med. 13, 1–7 (2003)
236. Srinivasan, R. S. et al. Lineage tracing demonstrates the venous origin of the mammalian lymphatic vasculature. Genes Dev. 21, 2422–2432 (2007)
237. Rensen, S. S., Doevendans, P. A. & van Eys, G. J. Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth. Heart J. 15, 100–108 (2007)
238. Mellgren, A. M. et al. Platelet-derived growth factor receptor beta signaling is required for efficient epicardial cell migration and development of two distinct coronary vascular smooth muscle cell populations. Circ. Res. 103, 1393–1401 (2008)
239. Wetzel, U., Lutsch, G., Haase, H., Ganten, U. & Morano, I. Expression of smooth muscle myosin heavy chain B in cardiac vessels of normotensive and hypertensive rats. Circ. Res. 83, 204–209 (1998)
240. Bochmann, L. et al. Revealing new mouse epicardial cell markers through transcriptomics. PLOS ONE 5, e11429 (2010)
241. Braitsch, C. M. & Yutzey, K. E. Transcriptional control of cell lineage development in epicardium-derived cells. J. Dev. Biol. 1, 92–111 (2013)
242. Geijtenbeek, T. B. et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100, 575–585 (2000)
243. Kuijpers, T. W. et al. CD20 deficiency in humans results in impaired T cell-independent antibody responses. J. Clin. Invest. 120, 214–222 (2010)
244. Hak, L. et al. NK cell compartment in patients with coronary heart disease. Immun. Ageing 4, 3 (2007)
245. Biassoni, R. et al. Human natural killer cell receptors: insights into their molecular function and structure. J. Cell. Mol. Med. 7, 376–387 (2003)
246. Ryan, J. C., Turck, J., Niemi, E. C., Yokoyama, W. M. & Seaman, W. E. Molecular cloning of the NK1.1 antigen, a member of the NKR-P1 family of natural killer cell activation molecules. J. Immunol. 149, 1631–1635 (1992)
247. Sewell, W. A. et al. The murine homologue of the T lymphocyte CD2 antigen: molecular cloning, chromosome assignment and cell surface expression. Eur. J. Immunol. 17, 1015–1020 (1987)
248. Clevers, H. et al. Characterization and expression of the murine CD3-epsilon gene. Proc. Natl Acad. Sci. USA 85, 8623–8627 (1988)
249. Veillette, A., Bookman, M. A., Horak, E. M. & Bolen, J. B. Pillars article: the CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck. 1994. J. Immunol. 185, 2650–2657 (2010)
250. Artis, D. & Spits, H. The biology of innate lymphoid cells. Nature 517, 293–301 (2015)
251. Dahlin, J. S., Ding, Z. & Hallgren, J. Distinguishing mast cell progenitors from mature mast cells in mice. Stem Cells Dev. 24, 1703–1711 (2015)
252. Eadie, A. L., Simpson, J. A. & Brunt, K. R. “Fibroblast” pharmacotherapy — advancing the next generation of therapeutics for clinical cardiology. J. Mol. Cell. Cardiol. 94, 176–179 (2016)
253. Metcalfe, D. D. et al. Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases. World Allergy Organ. J. 9, 7 (2016)
254. Bonecchi, R. et al. Up-regulation of CCR1 and CCR3 and induction of chemotaxis to CC chemokines by IFN-gamma in human neutrophils. J. Immunol. 162, 474–479 (1999)
255. Panopoulos, A. D. & Watowich, S. S. Granulocyte colony-stimulating factor: molecular mechanisms of action during steady state and ‘emergency’ hematopoiesis. Cytokine 42, 277–288 (2008)
256. Ryckman, C., Vandal, K., Rouleau, P., Talbot, M. & Tessier, P. A. Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J. Immunol. 170, 3233–3242 (2003)
257. Fregoso, S. P. & Hoover, D. B. Development of cardiac parasympathetic neurons, glial cells, and regional cholinergic innervation of the mouse heart. Neuroscience 221, 28–36 (2012)
258. Doerflinger, N. H., Macklin, W. B. & Popko, B. Inducible site-specific recombination in myelinating cells. Genesis 35, 63–72 (2003)
259. Deng, Y. et al. Direct visualization of membrane architecture of myelinating cells in transgenic mice expressing membrane-anchored EGFP. Genesis 52, 341–349 (2014)